Alpha-1-acid Glycoprotein (AGP, AAG)
<strong>Alpha-1-acid Glycoprotein (AGP, AAG)</strong>_x000D_ <strong>Catalog number:</strong> B2010406_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 41-43kDa_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Appearance:</strong> White Powder_x000D_ <strong>Applications:</strong> Highly pure (> 99%) human alpha-1-acid glycoprotein, also known as AGP or AAG._x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Orosomucoid, Agp, AAG, α1-Acid Glycoprotein, alpha 1 Acid Glycoprotein_x000D_ <strong>Grade:</strong> Biotechnology grade. All solid components are highly pure (minimum 95%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Ceciliani F, Lecchi C. The Immune Functions of α<sub>1</sub> Acid_x000D_ Glycoprotein. Curr Protein Pept Sci. 2019;20(6):505-524._x000D_ _x000D_ 2: Smith SA, Waters NJ. Pharmacokinetic and Pharmacodynamic Considerations for_x000D_ Drugs Binding to Alpha-1-Acid Glycoprotein. Pharm Res. 2018 Dec 28;36(2):30._x000D_ _x000D_ 3: Pitekova B, Uhlikova E, Kupcova V, Durfinova M, Mojto V, Turecky L. Can_x000D_ alpha-1-acid glycoprotein affect the outcome of treatment in a cancer patient?_x000D_ Bratisl Lek Listy. 2019;120(1):9-14._x000D_ _x000D_ 4: Zhang C, Clarke W, Hage DS. Glycoform Analysis of Alpha<sub>1</sub>-Acid_x000D_ Glycoprotein by Capillary Electrophoresis Using Electrophoretic Injection._x000D_ Methods Mol Biol. 2019;1972:41-56._x000D_ _x000D_ 5: Huang Z, Ung T. Effect of alpha-1-acid glycoprotein binding on_x000D_ pharmacokinetics and pharmacodynamics. Curr Drug Metab. 2013 Feb;14(2):226-38._x000D_ _x000D_ 6: Hochepied T, Berger FG, Baumann H, Libert C. Alpha(1)-acid glycoprotein: an_x000D_ acute phase protein with inflammatory and immunomodulating properties. Cytokine_x000D_ Growth Factor Rev. 2003 Feb;14(1):25-34._x000D_ _x000D_ 7: AlAjmi MF, Rehman MT, Khan RA, Khan MA, Muteeb G, Khan MS, Noman OM, Alsalme_x000D_ A, Hussain A. Understanding the interaction between α-1-acid glycoprotein (AGP)_x000D_ and potential Cu/Zn metallo-drugs of benzimidazole derived organic motifs: A_x000D_ multi-spectroscopic and molecular docking study. Spectrochim Acta A Mol Biomol_x000D_ Spectrosc. 2020 Jan 15;225:117457._x000D_ _x000D_ 8: Zhang C, Hage DS. Development and evaluation of silica-based lectin_x000D_ microcolumns for glycoform analysis of alpha<sub>1</sub>-acid glycoprotein. Anal_x000D_ Chim Acta. 2019 Oct 31;1078:189-199._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31564560/">9: Zhang C, Lott S, Clarke W, Hage DS. Development of a microcolumn one-site_x000D_ immunometric assay for a protein biomarker: Analysis of alpha<sub>1</sub>-acid_x000D_ glycoprotein. J Chromatogr A. 2020 Jan 11;1610:460558.</a>_x000D_ _x000D_ <strong>Products Related to Alpha-1-acid Glycoprotein (AGP, AAG) </strong> <a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>
Product Specifications
Short Description
Catalog Number: B2010406 (5 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Explore Other Products
Browse additional items from our catalog